Format

Send to

Choose Destination
ACS Med Chem Lett. 2019 Jul 23;10(9):1314-1321. doi: 10.1021/acsmedchemlett.9b00270. eCollection 2019 Sep 12.

Radiosensitization of Head and Neck Squamous Cell Carcinoma (HNSCC) by a Podophyllotoxin.

Author information

1
Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, California 94304, United States.
2
Department of Radiology, Canary Center at Stanford for Cancer Early Detection, Stanford University School of Medicine, Palo Alto, California 94304, United States.

Abstract

Surgical resection and radiotherapy are an effective treatment in many head and neck squamous cell carcinomas (HNSCC), but in others, the development of radiotherapy resistance limits treatment efficacy and permits disease progression. We developed a novel multiwell radiation dosing method to increase the throughput of our investigation of the activity of a novel podophyllotoxin SU093 in acting as a radiosensitizer in the HNSCC models FaDu and SCC-25. These in vitro studies showed that combining SU093 with 5 Grays ionizing radiation acted synergistically to increase HNSCC apoptosis and decrease its proliferation via inhibition of Nuclear factor, erythroid 2 like 2 (Nrf2), a key effector of the DNA damage response induced by ionizing radiation. Combined treatment reduced in vitro migration in a simulated wounding model while also promoting cell cycle arrest at the G2/M phase. These findings validate the potential of SU093 as a synergistic radiosensitizing agent for use in combination with localized radiotherapy in treatment resistant HNSCC.

PMID:
31531203
PMCID:
PMC6746081
[Available on 2020-09-12]
DOI:
10.1021/acsmedchemlett.9b00270

Supplemental Content

Full text links

Icon for American Chemical Society
Loading ...
Support Center